Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05412225

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Feasibility of Preoperative Radiotherapy in T3 and T4 Breast Cancer Patients Who Are Responders to Neoadjuvant Chemotherapy to Allow for Immediate Reconstruction: a Prospective Study

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study to test an alternative treatment approach that involves giving participants radiotherapy before their mastectomy (preoperative radiotherapy) and performing immediate reconstruction surgery at the time of mastectomy. The immediate reconstruction surgery is called an immediate autologous reconstruction (IR) and is different than the standard reconstruction surgery people with T4 breast cancer have. IR is a surgical procedure where immediately following your mastectomy, the surgeon takes tissue from another part of your body and uses it to re-create your breast. The standard reconstruction surgery occurs later and can be done with an implant or tissue from your body. The main purpose of this study to find out if the alternative treatment approach shown above is feasible. The study will see how safe this alternative treatment approach is compared with the standard treatment approach.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPre-neoadjuvant radiotherapy (NART) biopsyParticipants will undergo pre-NART core biopsy guided by post-NAC MRI to the area of residual enhancement or to the previously biopsied cancer if no residual enhancement remains
RADIATIONNeoadjuvant radiotherapyAfter biopsy, participants will undergo neoadjuvant radiotherapy/NART
PROCEDUREUnilateral total mastectomy with axillary lymph node dissectionAt 2-6 weeks after completion of NART, participants will undergo unilateral MRM (total mastectomy with axillary lymph node dissection), with resection of all involved breast skin. Skin-sparing mastectomy will not be permitted. All patients will also undergo simultaneous unilateral autologous-based breast reconstruction with DIEP, ms-TRAM, or latissimus dorsi flap.

Timeline

Start date
2022-06-06
Primary completion
2026-06-06
Completion
2026-06-06
First posted
2022-06-09
Last updated
2026-02-11

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05412225. Inclusion in this directory is not an endorsement.